An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy-Reference-Cited by-同舟云学术

An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy

Published:2021-06-11 Issue:4 Volume:479 Page:697-703
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Sasaki Motoko^ORCID,Sato Yasunori

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00428-021-03132-3.pdf

Reference28 articles.

1. Dumonceau JM, Delhaye M, Charette N, Farina A (2020) Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1. Ther Adv Gastroenterol 13:1756284820927292. https://doi.org/10.1177/1756284820927292

2. Kawashima H, Itoh A, Ohno E, Miyahara R, Ohmiya N, Tanaka T, Shimoyama Y, Nakamura S, Ebata T, Nagino M, Goto H, Hirooka Y (2013) Diagnostic and prognostic value of immunohistochemical expression of S100P and IMP3 in transpapillary biliary forceps biopsy samples of extrahepatic bile duct carcinoma. J Hepatobiliary Pancreat Sci 20:441–447. https://doi.org/10.1007/s00534-012-0581-z

3. Singhi AD, Nikiforova MN, Chennat J, Papachristou GI, Khalid A, Rabinovitz M, Das R, Sarkaria S, Ayasso MS, Wald AI, Monaco SE, Nalesnik M, Ohori NP, Geller D, Tsung A, Zureikat AH, Zeh H, Marsh JW, Hogg M, Lee K, Bartlett DL, Pingpank JF, Humar A, Bahary N, Dasyam AK, Brand R, Fasanella KE, McGrath K, Slivka A (2020) Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Gut 69:52–61. https://doi.org/10.1136/gutjnl-2018-317817

4. De Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, McHenry L Jr, Watkins JL, Lehman GA (2002) Tissue sampling at ERCP in suspected malignant biliary strictures (part 1). Gastrointest Endosc 56:552–561. https://doi.org/10.1067/mge.2002.128132

5. de Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, McHenry L Jr, Watkins JL, Lehman GA (2002) Tissue sampling at ERCP in suspected malignant biliary strictures (part 2). Gastrointest Endosc 56:720–730. https://doi.org/10.1067/mge.2002.129219

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment;Genes & Diseases;2024-03

2. Ancillary tests for hepatobiliary neoplasms: what we know and what we need to know;Human Pathology;2023-11

3. Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine;Archives of Pathology & Laboratory Medicine;2023-06-19

4. Bile duct adenoma and small‐sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components;Histopathology;2023-05-04

5. EZH1/2 as targets for cancer therapy;Cancer Gene Therapy;2022-11-11